Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Haarmann-Stemmann

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Biochemical Pharmacology|May 20, 2024
The aryl hydrocarbon receptor in environmentally induced cancersThomas Haarmann-Stemmann
Dermatologie (Heidelberg, Germany)|December 19, 2025
[Per- and polyfluoroalkyl substances-"forever chemicals" and skin]Charlotte Esser, Thomas Haarmann-Stemmann
Pharmacology & Therapeutics|February 20, 2018
Modulation of CYP1A1 metabolism: From adverse health effects to chemoprevention and therapeutic optionsMelina Mescher, Thomas Haarmann-Stemmann
Biological Chemistry|September 16, 2006
The arylhydrocarbon receptor repressor (AhRR): structure, expression, and functionThomas Haarmann-Stemmann, Josef Abel
Biological Chemistry|September 28, 2010
An introduction to the molecular basics of aryl hydrocarbon receptor biologyJosef Abel, Thomas Haarmann-Stemmann
The Journal of Investigative Dermatology|May 27, 2025
"Forever Chemicals" - Cutaneous exposure to per- and polyfluoroalkyl substances (PFAS): Cause for concern?Thomas Haarmann-Stemmann, Charlotte Esser
Experimental Dermatology|June 30, 2015
COX inhibition enhances inflammatory immune cell infiltration in UV-irradiated human skin: implications for the treatment of sunburnMotoki Nakamura, Thomas Haarmann-Stemmann, Jean Krutmann
Biochemical Pharmacology|October 14, 2008
Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathwaysThomas Haarmann-Stemmann, Hanno Bothe, Josef Abel
The Journal of Investigative Dermatology|August 14, 2015
The Janus-Faced Role of Aryl Hydrocarbon Receptor Signaling in the Skin: Consequences for Prevention and Treatment of Skin DisordersThomas Haarmann-Stemmann, Charlotte Esser, Jean Krutmann
Frontiers in Pharmacology|September 5, 2018
Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!Marius Pollet, Jean Krutmann, Thomas Haarmann-Stemmann
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Biochemical Pharmacology|May 20, 2024
The aryl hydrocarbon receptor in environmentally induced cancersThomas Haarmann-Stemmann
Dermatologie (Heidelberg, Germany)|December 19, 2025
[Per- and polyfluoroalkyl substances-"forever chemicals" and skin]Charlotte Esser, Thomas Haarmann-Stemmann
Pharmacology & Therapeutics|February 20, 2018
Modulation of CYP1A1 metabolism: From adverse health effects to chemoprevention and therapeutic optionsMelina Mescher, Thomas Haarmann-Stemmann
Biological Chemistry|September 16, 2006
The arylhydrocarbon receptor repressor (AhRR): structure, expression, and functionThomas Haarmann-Stemmann, Josef Abel
Biological Chemistry|September 28, 2010
An introduction to the molecular basics of aryl hydrocarbon receptor biologyJosef Abel, Thomas Haarmann-Stemmann
The Journal of Investigative Dermatology|May 27, 2025
"Forever Chemicals" - Cutaneous exposure to per- and polyfluoroalkyl substances (PFAS): Cause for concern?Thomas Haarmann-Stemmann, Charlotte Esser
Experimental Dermatology|June 30, 2015
COX inhibition enhances inflammatory immune cell infiltration in UV-irradiated human skin: implications for the treatment of sunburnMotoki Nakamura, Thomas Haarmann-Stemmann, Jean Krutmann
Biochemical Pharmacology|October 14, 2008
Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathwaysThomas Haarmann-Stemmann, Hanno Bothe, Josef Abel
The Journal of Investigative Dermatology|August 14, 2015
The Janus-Faced Role of Aryl Hydrocarbon Receptor Signaling in the Skin: Consequences for Prevention and Treatment of Skin DisordersThomas Haarmann-Stemmann, Charlotte Esser, Jean Krutmann
Frontiers in Pharmacology|September 5, 2018
Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!Marius Pollet, Jean Krutmann, Thomas Haarmann-Stemmann
Pageof 8